| Literature DB >> 27276911 |
Io Antonopoulou1, Simona Varriale2, Evangelos Topakas3, Ulrika Rova1, Paul Christakopoulos1, Vincenza Faraco4.
Abstract
Cosmeceuticals are cosmetic products containing biologically active ingredients purporting to offer a pharmaceutical therapeutic benefit. The active ingredients can be extracted and purified from natural sources (botanicals, herbal extracts, or animals) but can also be obtained biotechnologically by fermentation and cell cultures or by enzymatic synthesis and modification of natural compounds. A cosmeceutical ingredient should possess an attractive property such as anti-oxidant, anti-inflammatory, skin whitening, anti-aging, anti-wrinkling, or photoprotective activity, among others. During the past years, there has been an increased interest on the enzymatic synthesis of bioactive esters and glycosides based on (trans)esterification, (trans)glycosylation, or oxidation reactions. Natural bioactive compounds with exceptional theurapeutic properties and low toxicity may offer a new insight into the design and development of potent and beneficial cosmetics. This review gives an overview of the enzymatic modifications which are performed currently for the synthesis of products with attractive properties for the cosmeceutical industry.Entities:
Keywords: Anti-aging; Anti-inflammatory; Anti-microbial; Anti-oxidant; Anti-wrinkling; Bacterial; Feruloyl esterases; Fungal; Glycosidases; Laccases; Lipases; Photoprotective; Proteases; Skin whitening; Tannases; Transferases
Mesh:
Substances:
Year: 2016 PMID: 27276911 PMCID: PMC4939304 DOI: 10.1007/s00253-016-7647-9
Source DB: PubMed Journal: Appl Microbiol Biotechnol ISSN: 0175-7598 Impact factor: 4.813
Fig. 1Reaction examples
Lipase-catalyzed reactions
| Product | Donor | Acceptor | Enzyme | Solvent system | Yield (time) | T (°C) | Reference |
|---|---|---|---|---|---|---|---|
| Examples of α-hydroxy acid derivatives | |||||||
| C6–C18 lactates | C6–C18 fatty alcohols | Lactic acid | Novozym 435 | Acetonitrile | 94–96 % (48 h) | 30 | Torres and Otero |
| C6–C18 glycolates | C6–C18 fatty alcohols | Glycolic acid | Novozym 435 | Hexane | 91 % (48 h) | ||
| Ethyl glycoside lactate | Ethyl glycoside | Butyl lactate | Novozym 435 | Solvent-free | 95 % (36 h) | 60 | Wei et al. |
| β-Methyl glycoside malate/glycolate/lactate | β-Methyl glycoside | Malic/glycolic/lactic acid | Novozym 435 |
| 48–75 % (120 h) | 60 | Park et al. |
| Palmitoyl or stearoyl lactic acid | C16 or C18:0 fatty acid | Lactic acid | Lipozyme IM20 | Ethyl methyl ketone | 37.5–40 % (72 h) | 37 or 60 | Kiran and Divakar |
| Examples of kojic acid derivatives | |||||||
| Kojic acid monoricinoleate | Ricinoleic acid | Kojic acid | Lipozyme TL IM | Solvent-free | 87.4 % (6 h) | 80 | El-Boulifi et al. |
| Kojic acid monooleate | Oleic acid | Kojic acid | Amano G | Acetonitrile | 36.7 % (48 h) | 50 | Liu and Shaw |
| Kojic acid monopalmitate | Palmitic acid | Kojic acid | RM IM | Acetonitrile | 29.30 % (12 h) | 50 | Lajis et al. |
| Examples of lipoic acid derivatives | |||||||
| Pyridoxine-O-lipoate (5′ and 4′)/tyrosol-8-O-lipoate/tyramin-8-N-lipoate | Pyridoxine (vitamin B6) | Lipoic acid | CNTs-C6-NH2-CaLB or CNTs-C11-CH3-CaLB | (mtoa)NTf2 | 91.1–99.5 % (72 h) | 60 | Papadopoulou et al. |
| Tyrosol/tyramine | (bmim)PF6 | ||||||
| Phenolic lipoates | 4-Hydroxybenzyl alcohol/vanillyl alcohol/4-hydroxyphenyl ethanol/coniferyl alcohol/dihydroxybenzyl alcohol/dihydroxyphenyl ethanol | Lipoic acid | Novozym 435 | 2-Butanone: hexane | 64–80 % (15 h) | 25 | Kaki et al. |
| Octanyl lipoate | n-Octanol | α-Lipoic acid | Whole-cell lipase from | Heptane | 75.2 % (48 h) | 50 | Yang et al. |
| Examples of arbutin derivatives | |||||||
| Arbutin lipoate | α-Lipoic acid | β-Arbutin | Type B lipase from |
| – (7 days) | 55 | Ishihara et al. |
| C2–C18 alkyl arbutin esters | Vinyl esters of C2–C18 aliphatic alcohols | β-Arbutin | Immobilized lipase from | Anhydrous THF | 82–99 % (0.5–72 h) | 35 | Yang et al. |
| Arbutin phenolic acid esters | Vinyl esters of aromatic acids | 30–99 % (4–96 h) | 50 | Yang et al. | |||
| Arbutin fatty acid esters | Saturated fatty acids (C6–C18) | β-Arbutin | Chirazyme L-2 C2 | Acetonitrile | Up to 45 % (2 days) | 60 | Nagai et al. |
| Arbutin ferulate | Ferulic acid | β-Arbutin | Type B lipase from |
| 57 % (7 days) | 55 | Ishihara et al. |
| Vinyl ferulate | p-Arbutin | Novozym 435 | Acetonitrile | 50 % (−) | 45 | Chigorimbo-Murefu et al. | |
| Examples of vitamin derivatives | |||||||
| L-Ascorbyl palmitate | Palmitic acid | L-Ascorbic acid | Lipase from | Hexane | 97 % (6 h) | 50 | Bradoo et al. |
| Methyl palmitate | Lipase from | Solvent-free (under microwave irradiation) | 83 % (40 min) | 80 | Kidwai et al. | ||
| Ethyl palmitate | Lipozyme TL IM |
| 20 % (120 h) | 40 | Reyes-Duarte et al. | ||
| Vinyl palmitate | 100 % (120 h) | ||||||
| Tripalmitin | 50 % (140 h) | ||||||
| L-Ascorbyl oleate | Oleic acid | L-Ascorbic acid | Novozym 435 |
| 82 % (52 h) | 65 | Viklund et al. |
| Methyl oleate | Lipozyme TL IM |
| 50 % (−) | 60 | Reyes-Duarte et al. | ||
| Triolein | Novozym 435 |
| 84 % (140 h) | 40 | Moreno-Perez et al. | ||
| Olive oil | Novozyme 435-PEI | 85 % (48 h) | 45 | ||||
| Conjugated linoleoyl ascorbates | C9t11CLA | L-Ascorbic acid | Chirazyme L-2 C3 | Acetone | ~80 % (~48 h) | 50 | Watanabe et al. |
| L-Ascorbyl benzoate | Benzoic acid | L-Ascorbic acid | Novozym 435 | Cyclohexanone | 47.7 % (48) | 66.6 | Lv et al. |
| L-Ascorbyl acetate | Vinyl acetate | L-Ascorbic acid | Lipozyme TLIM | Acetone | 99 % (4) | 40 | Zhang et al. |
| Vitamin E succinate | Succinic anydride | Rac-all-α-tocopherol | Succinyl-Novozym 435 | DMSO: | 94.4 % (48 h) | 40 | Yin et al. |
| Vitamin E acetate | Vinyl acetate | δ-Tocopherol | Novozym 435 |
| 65 % (16 days) | 60 | Torres et al. |
| α-Tocopherol | >45 % (16 days) | ||||||
| Vitamin E ferulate | Ethyl ferulate | Vitamin E | Novozym 435 | Solvent-free | 25.2 % (72 h) | 60 | Xin et al. |
| Sugar or ascorbyl retinyl adipates | Sorbitol/fructose/glucose/saccharose/maltose/ascorbic acid | Retinyl adipate | Novozym 435 |
| 22–80 % (45 h) | 40 | Rejasse et al. |
| Vitamin A lactate | Lactic acid | Vitamin A acetate | Immobilized lipase from | Hexane | 32 % (7 h) | 30 | Liu et al. |
| Methyl lactate | Retinol | Lipozyme | 86 % (50 h) | 55 | Maugard and Legoy | ||
| Vitamin A oleate | Methyl oleate | Hexane | 90 % (50 h) | ||||
| Oleic acid | Retinyl acetate | Immobilized lipase from | 79 % (7 h) | 30 | Liu et al. | ||
| Vitamin A saturated fatty acid esters (C6–C18) | C6–C18 saturated fatty acids | Hexane | 51–82 % (7 h) | ||||
| Vitamin A methyl succinate | Dimethyl succinate | Retinol | Lipozyme | Hexane | 77 % (50 h) | 55 | Maugard and Legoy |
| Examples of flavonoid derivatives | |||||||
| Quercetin derivatives | C18–C12 fatty acids | Isoquercetin | Novozym 435 | Acetone or acetonitrile | 81–98 % (18–24 h) | 45–60 | Ziaullah |
| Ethyl esters of C4–C18 fatty acids | Novozym 435 |
| 38–66 % (72 h) | 65 | Salem et al. | ||
| Cinnamic acids | Novozym 435 |
| 17–89 % (7 days) | 60 | Stevenson et al. | ||
| Dibenzyl malonate | Lipase from | Me2CO: pyridine | 74 % (12 days) | 45 | Riva | ||
| Vinyl acetate | PSL-C II | Acetone | 84 % (96 h) | 50 | Chebil et al. | ||
| Quercetin | 100 % (24 h) | ||||||
| Silybin derivatives | Divinyl ester of decanoic acid | Silybin | Novozym 435 | Acetonitrile | 26–66 % (72 h) | 45 | Vavrikova et al. |
| Vinyl butanoate | Novozym 435 | Acetone | 100 % (24–96 h) | 50 | Theodosiou et al. | ||
| Vinyl acetate | Novozym 435 | Acetone | 92 % (48 h) | 35 | Gazak et al. | ||
| Esculin derivatives | Fatty acids, dicarboxylic acids, other cyclic acids | Esculin | Novozym 435 |
| 13–90 % (12 h) | 60 | Ardhaoui et al. |
| Palmitic acid | Novozym 435 | TOMA TF2N | >96 % (6 days) | 60 | Lue et al. | ||
| Vinyl butyrate | Novozym 435 | [Bmim]BF6 | 90.6 % (72 h) | 60 | Katsoura et al. | ||
| Phloridzin derivatives | C2–C18 fatty acids | Phloridzin | Novozym 435 | Acetonitrile | 70–90 % (7 days) | 65 | Milisavljecic et al. |
| Ethyl cinnamate | Novozym 435 | Solvent-free | 100 % (4 h) | 80 | Enaud et al. | ||
| Hesperedin derivatives | Decanoic acid | Hesperidin | Novozym 435 | [Bmim]BF4: acetone | 53.6 % (96 h) | 50 | Branco de Araujo et al. |
| Palmitic acid | Novozym SP435 |
| Up to 40 % (12 h) | 60 | Ardhaoui et al. | ||
| Vinyl acetate | Hesperetin | PSL-C II | Acetonitrile | 30 % (96 h) | 50 | Chebil et al. | |
| Rutin derivatives | C4–C18 fatty acids | Rutin | CALB |
| 27–62 % (168 h) | 60 | Viskupicova et al. |
| Ethyl linoleate | Novozym 435 | Acetone | 50 % (96 h) | 50 | Mellou et al. | ||
| Methyl palmitate | Novozym 435 |
| 30 % (48 h) | 60 | Passicos et al. | ||
| Vinyl esters of fatty acids | Novozym 435 | [Bmim]BF4 | 15–65 % (96 h) | 60 | Katsoura et al. | ||
| Dicarboxylic acids, fatty acids, other cyclic acids | Novozym 435 |
| 10–90 % (−) | 60 | Ardhaoui et al. | ||
| Divinyl dicarboxylate | Novozym 435 |
| 36 % (4 days) | 50 | Xiao et al. | ||
| Dibenzyl malonate | Lipase from | Me2CO: pyridine | 79 % (12 h) | 45 | Riva | ||
| Vinyl cinnamate | Chirazyme L-2 | Acetone | 28 % (14 h) | 37 | Ishihara et al. | ||
| Naringin derivatives | α-Linolenic acid, linoleic, oleic acid | Naringin | Novozym 435 |
| 83.2–90.1 % (72 h) (assisted by ultrasound irradiation) | 50 | Zheng et al. |
| Stearic acid | Novozym 435 |
| 46 % (24 h) | 60 | Duan et al. | ||
| Vinyl butyrate | Novozym 435 | [Bmim]BF4 | 86.9 % (100 h) | 60 | Katsoura et al. | ||
| Methyl palmitate | Novozym 435 |
| 92 % (48 h) | 60 | Passicos et al. | ||
| C10–C12 vinyl esters of saturated fatty acids | Novozym 435 | Acetone | 22–70 % (96 h) | 50 | Mellou et al. | ||
| PUFA from byfish products | Novozym 435 |
| 30 % (96 h) | 50 | Mbatia et al. | ||
| Vinyl laurate | Lipozyme IM TL |
| 90 % (30 min) | 52 | Luo et al. | ||
| Lauric acid | Chirazyme L-2 C2 | Acetonitrile | ~45 % (~30 h) | 60 | Watanabe et al. | ||
| Ricinoleic acid | Immobilized lipase from | Acetone | 24 % (120 h) | 50 | Almeida et al. | ||
| Castor oil | 33 % (120 h) | ||||||
| Vinyl cinnamate | Chirazyme L-2 | Acetone | 64 % (14 days) | 37 | Ishihara et al. | ||
| Dibenzyl malonate | Lipase from | Acetone: pyridine | 69 % (12 days) | 45 | Riva | ||
| Vinyl acetate | Naringenin | PSL-C II | Acetonitrile | 100 % (96 h) | 50 | Chebil et al. | |
| Examples of hydroxycinnamic acid derivatives | |||||||
| Feruloylated lipids | Ferulic acid | Glycerol | Chirazyme L2 C-2 | Solvent-free | 80 % (>3 h) | 80 | Matsuo et al. |
| Trilinolenin | Novozym 435 | Hexane:2-butanone | 14 % (5 days) | 55 | Sabally et al. | ||
| Flaxseed oil | Novozym 435 | SCCO2 medium | 57.6 % (27.5 h) | 80 | Ciftci and Saldana | ||
| Ethyl ferulate | Oleyl alcohol | Novozym 435 | Hexane | 99.17 % (4 days) | 60 | Chen et al. | |
| Triolein | Novozym 435 | Toluene | 77 % (144 h) | 60 | Compton et al. | ||
| Olive oil | Novozym 435 | 2M2B: toluene | 59.6 % (2.34 h) | 60 | Radzi et al. | ||
| Tributyrin | Novozym 435 | Solvent-free | 94.2 % (120 h) | 50 | Zheng et al. | ||
| Monostearin | Novozym 435 | Ethanol | 97.8 % (23 h) | 74 | Sun et al. | ||
| Soybean oil | Novozym 435 | Glycerol | 70 % (140 h) | 60 | Laszlo and Compton | ||
| Fish oil | Novozym 435 | Toluene | 80.4 % (5 days) | 70 | Yang et al. | ||
| Phosphatidylcholine | Novozym 435 | Chloroform | 40.51 % (4 days) | 55 | Yang et al. | ||
| Glycerol | Novozym 435 | EMIMTF2N | 100 % (12 h) | 70 | Sun et al. | ||
| Oleic acid | Novozym 435 | Solvent-free | 96 % (1.33 h) | 60 | Sun et al. | ||
| Glyceryl ferulate | Oleic acid | Novozym 435 | [Bmim]PF6 | 100 % (3 h) | 80 | Sun et al. | |
| Vinyl ferulate | Triolein | Novozym 435 | Solvent-free | 91.9 % (62 h) | 55 | Yu et al. | |
| Methyl caffeate | Caffeic acid | Methanol | Novozym 435 | [Bmim][Tf2N] | 99.79 % (9 h) | 75 | Wang et al. |
| Propyl caffeate | Methyl caffeate | 1-Propanol | Novozym435 | [Bmim][CF3SO3] | 99.5 % (2.5 h) | 60 | Wang et al. |
| Sitosteryl hydroxycinnamates | Vinyl ferulate/caffeate/sinapate | Sitosterol | Lipase type VII from | Hexane:2-butanone | 30–90 % (−) | 45 | Tan and Shahidi |
| Examples of galloyl derivatives | |||||||
| Propyl gallate | Gallic acid | 1-Propanol | Immobilized lipase from | Hexane | 90 % (6 h) | 52 | Bouaziz et al. |
| Mono-, di-, and tri- acetylated EGCG | Vinyl acetate | EGCG | Lipozyme RM IM | Acetonitrile | 87.37 % (1.13 h) | 40 | Zhu et al. |
| Catechin | Vinyl acetate | Catechin | PCL | Acetonitrile | 70 % (48 h) | 45 | Lambusta et al. |
Novozym 435: lipase B from Candida antarctica immobilized on a macroporous acrylic resin (CALB); lipozyme IM20/lipozyme RM IM: lipase from Rhizomucor miehei immobilized on duolite anion exchange resion; lipozyme TL IM: lipase from Thermomyces laniginosus immobilized on silica granulation; amano G: lipase from Penicillum camemberti; CNTs-C6-NH2-CaLB, CNTs-C11-CH3-CAL-B: novozym 435 functionalized with various multi-walled carbon nanotube groups; chirazyme L-2: immobilized lipase B from C. Antarctica; succinyl-novozym 435: novozym 435 modified with succinic anhydride; PSL-C II, PCL: lipase from Pseudomonas cepacia
Ferulic acid esterase-catalyzed reactions
| Product | Donor | Acceptor | Enzyme | Solvent system | Yield (time) | T (°C) | Reference |
|---|---|---|---|---|---|---|---|
| 1-Pentyl ferulate | Ferulic acid | 1-Pentanol | FAEA | CTAB: hexane: pentanol: buffer | 60 % (n.q.) | 40 | Giuliani et al. |
| 1-Butyl ferulate | Methyl ferulate | 1-Butanol | CLEAs immobilized Ultraflo L | Hexane: 1-butanol: buffer | 97 % (144 h) | 37 | Vafiadi et al. |
| 1-Butyl sinapate | Methyl sinapate | 1-Butanol | AnFaeA | Hexane: 1-butanol: buffer | 78 % (120 h) | 35 | Vafiadi et al. |
| 2-Butyl sinapate | Methyl sinapate | 2-Butanol | AnFaeA | Hexane: 2-butanol: buffer | 9 % (120 h) | 37 | Vafiadi et al. |
| 1-Butyl caffeate | Methyl caffeate | 1-Butanol | StFae-A | Hexane: 1-butanol: buffer | Up to 25 % (144 h) | 35 | Topakas et al. |
| 1-Butyl- | Methyl | 1-Butanol | FoFae-I | Hexane: 1-butanol: buffer | Up to 70 % (144 h) | 35 | Topakas et al. |
| 1-Propyl- |
| 1-Propanol | FoFae-II | Hexane: 1-propanol: buffer | 75 % (224 h) | 30 | Topakas et al. |
| 1-Propyl- |
| 70 % (224 h) | |||||
| Glycerol sinapate | Sinapic acid | Glycerol | AnFaeA | [C5OHmim][PF6]: buffer | 76.7 % (24 h) | 50 | Vafiadi et al. |
| Methyl sinapate | Up to 7 % (120 h) | ||||||
| Glycerol ferulate | Ferulic acid | Glycerol | FAE-PL | Glycerol: DMSO: buffer | 81 % (n.q.) | 50 | Tsuchiyama et al. |
| Diglycerol ferulates (mixture of isomers) | Ferulic acid | Diglycerin S | FAE-PL | Diglycerin S: DMSO: buffer | 95 % (12 h) | 50 | Kikugawa et al. |
| Glycerol |
| Glycerol | FAE-PL | Glycerol: DMSO: buffer | ~60 % (72 h) | 50 | Tsuchiyama et al. |
|
| Methyl ferulate |
| StFae-C | Hexane: | Up to 50 % (120 h) | 35 | Vafiadi et al. |
| Ethyl ferulate | 6.3 % (−) | ||||||
|
| Methyl ferulate |
| Hexane: | 45 % (−) | 35 | Vafiadi et al. | |
| Ferulic acid |
| Multifect P3000 | Hexane: 1-butanol:buffer | 36.7 % (144 h) | 35 | Couto et al. | |
|
| Ferulic acid |
| Depol 670 | 61.5 % (144 h) | |||
|
| Ferulic acid | D-Xylose | Hexane: 2-butanone:buffer | 37.3 % (144 h) | |||
| Feruloyl raffinose | Ferulic acid | Raffinose | Depol 740L | Hexane: 2-butanone:buffer | 11.9 % (7 days) | 35 | Couto et al. |
| Feruloyl galactobiose | Ferulic acid | Galactobiose | Hexane: 1,4-dioxane:buffer | 26.8 % (144 h) | |||
| Feruloyl xylobiose | Ferulic acid | Xylobiose | Hexane: 2-butanone:buffer | 9.4 % (144 h) | |||
| Feruloyl arabinodiose | Ferulic acid | Arabinodiose | 7.9 % (144 h) | ||||
| Feruloyl sucrose | Ferulic acid | Sucrose | 13.2 % (n.q.) | ||||
| Feruloyl FOS | Ferulic acid | FOS | 9.6 % (n.q.) |
FAEA: FAE from Aspergillus niger; Ultraflo L, Depol 740L: multi-enzymatic preparation from Humicola insolens; AnFaeA: type A FAE from A. niger; StFae-A, StFae-C: FAE from Sporotrichum thermophile ATCC 34628; FoFae-I, FoFae-II: FAE from Fusarium oxysporum; FAE-PL: FAE from A. niger purified from the commercial preparation Pectinase PL“Amano”; Multifect P3000: multi-enzymatic preparation from Bacillus amyloliquefaciens; Depol 670: multi-enzymatic preparation from Trichoderma reesei
Tannase-catalyzed reactions
| Product | Donor | Acceptor | Enzyme | Solvent system | Yield (time) | T (°C) | Reference |
|---|---|---|---|---|---|---|---|
| Methyl gallate | Gallic acid | Methanol | Tannase from | Hexane | 90.7 % (8 h) | 50 | Sharma and Saxena |
| Propyl gallate | 1-Propanol | 94.8 % (8 h) | |||||
| Tannic acid | CNBr-agarose immobilized tannase from | Buffer | 88 % (48 h) | 60–75 | Goncalves et al. | ||
| Methyl gallate | CNBr-agarose immobilized tannase from | Buffer | 55 % (−) | 25 | Fernandez-Lorente et al. | ||
| C1–C12 acyl gallates | Gallic acid | C1–C12 fatty alcohols | Tannase from | Solvent-free | 10–95 % (18–48 h) | RT | Weetall |
| C3–C5 diol gallates (strong indication of more than one form of ester) | Diols | 50–80 % (24 h) | |||||
| Catechin gallate | Gallic acid | Catechin | Tannase from | [ΒMIM][MEESO4]:buffer | 1.3 % (20 h) | RT | Raab et al. |
| Epicatechin gallate | Epicatechin | 5.4 % (20 h) | |||||
| Epigallocatechin gallate | Epigallocatechin | 3.1 % (20 h) |
Protease-catalyzed reactions
| Product | Donor | Acceptor | Enzyme | Solvent system | Yield (time) | T (°C) | Reference |
|---|---|---|---|---|---|---|---|
| 7- | Kojic acid | Divinyl adipate | Bioprase from | Dimethylformamide | 25 % (7 days) | 30 | Raku and Tokiwa |
| 7- | Vinyl hexanoate/octanoate/decanoate | 13–27 % (7 days) | |||||
| 6- | Arbutin | Undecylenic acid vinyl ester | Bioprase from | Dimethylformamide | 62 % (7 days) | 40 | Tokiwa et al. |
| 3″- | Rutin | Divinyl succinate/sebacate | Subtilisin from | Pyridine | 12.8/19.8 % (4 days) | 50 | Xiao et al. |
| Vinylsuccinyl/vinylglutaryl/vinyladipoyl/dinylnonanedioyl/vinylsebacoyl/vinyltridecanedioyl-troxerutin | Troxerutin | Divinyl succinate/glutarate/adipate/nonanedioate/sebacate/decanedioate | Subtilisin from | Pyridine | 10.6–33.10 % (4 h) | 50 | Xiao et al. |
| 2- | Sucrose | Vinyl laurate | Alkaline protease from | Dimethylformamide:pyridine | 50–60 % (24 h) | 45 | Pedersen et al. |
| 6-O-Vinyladipoyl-D-glucose/-D-mannose/-D-galactose/-methyl D-galactoside | D-Glucose/D-mannose/D-galactose/α-methyl D-galactoside | Divinyl adipate | Alkaline protease from | Dimethylformamide | 49–74 % (7 days) | 35 | Kitagawa et al. |
Transferase catalyzed reactions
| Product | Donor | Acceptor | Enzyme | Solvent system | Yield (time) | T (°C) | Reference |
|---|---|---|---|---|---|---|---|
| EGCG glycosides (EGCG-G1, EGCG-G2A, EGCG-G2B) | Sucrose | EGCG | Glucansucrase from | Buffer | 62.2 % (6.5 h) | 28 | Moon et al. |
| EC glycosides (EC3A, EC3B, EC3C, EC4A) | β-Cyclodextrin | (−)-Epicatechin | β-Cyclodextrin transferase from | Βuffer | 18.1 % (24 h) | 50 | Aramsangtienchai et al. |
| Catechin 3′-O-α-D-glucopyranoside | Maltose | (+)-Catechin | Glycosyltransferase from | Buffer | 13.7 % (24 h) | 45 | Nakahara et al. |
| Catechin 3′-O-α-D-glucopyranoside (main product) | Starch | Cyclodextrin glucanotransferase from | 18.3 % (40 h) | 40 | Funayama et al. | ||
| Catechin 3′-O-α-D-glucopyranoside | Maltose | Enzyme with transfer activity from | 57.1 % (36 h) | 45 | Sato et al. | ||
| Hydroquinone fructoside | Sucrose | Hydroquinone | Levansucrase from | Buffer | 14 % (6 h) | 28 | Kang et al. |
| β-Αrbutin-α-G1/β-arbutin-α-G2 | Sucrose | β-Arbutin | Glucansucrase from | Buffer | 27.1 % (10 h) | 28 | Moon et al. |
| Starch | β-Arbutin | Cyclomaltodextrin glucanotransferase from | Buffer | 70 % (16 h) | 40 | Sugimoto et al. | |
| α-Αrbutin-α-G1/β-arbutin-α-G2 | α-Arbutin | Buffer | 70 % (16 h) | 40 | Sugimoto et al. | ||
| α-Arbutin | Sucrose | Hydroquinone | Amylosucrase from | Buffer | 90 % (24 h) | 35 | Seo et al. |
| α-Arbutin (in a mixture of products, G2–G7) | α-Cyclodextrin | Cyclodextrin glycosyltranferase from | Buffer | 30.0 % (24 h) | 40 | Mathew and Adlercreutz | |
| β-Arbutin-α-glycoside | Sucrose | β-Arbutin | Amylosucrase from | Buffer | 98 % (−) | 35 | Seo et al. |
| Kojic acid glycosides (5- | Kojic acid | Sucrose phosphorylase from | DMSO:buffer | 19.7 % (24 h) | 42 | Kitao & Serine | |
| Quercetin glycosides (3′- | Quercetin | Glucansucrase from | Acetone | 23.1 % (5 h) | 28 | Moon et al. | |
| Ampelopsin glycosides up to 5 units(4′- | Ampelopsin | Dextransucrase from | DMSO: buffer | 87.3 % (1 h) | 28 | Woo et al. | |
| Astragalin glycosides (kaempferol-3- | Sucrose | Astragalin | 24.5 % (5 h) | 28 | Kim et al. | ||
| Ascorbic acid glycosides (2- | α-Cyclodextrin | Ascorbic acid | Cyclomaltodextrin glucanotransferase form | Buffer | 45.6 % (1 h) | 60 | Aga et al. |
| Benzoyl glycosides (1-O-benzoyl-α-D-, 2-O-benzoyl-α-D- and 2-O-benzoyl-β-D-glucopyranoside) | Sucrose | Benzoic acid | Sucrose phosphorylase from | Buffer | 70 % (48 h) | 37 | Sugimoto et al. |
Glucosidase-catalyzed reactions
| Product | Donor | Acceptor | Enzyme | Solvent system | Yield (time) | T (°C) | Reference |
|---|---|---|---|---|---|---|---|
| 4-Hydroxyphenyl-β-isomaltoside | Sucrose | Arbutin | α-Glucosidase from | Buffer | 50 % (20 h) | 40 | Milosavić et al. |
| Hydroquinone α-D-glucopyranoside | Maltose | Hydroquinone | α-Glucosidase from | Buffer | 13 % (20 h) | 30 | Prodanović et al. |
| Hydroquinone α-D-isomaltoside | 15 % (20 h) | ||||||
| 2-(α-D-Glucopyranosyl)methyl-2,5,7,8-tetramethylchroman-6-ol | Maltose | 2-Hydroxymethyl-2,5,7,8-tetramethylchroman-6-ol (vitamin E derivative) | α-Glucosidase from | DMSO | (20 h) | 40 | Murase et al. |
| β-D-Glucosyl-(1-6)-arbutin | Cellobiose | Arbutin | β-Glucosidase from | Buffer | 2.8 % (12 h) | 80 | Jun et al. |
| β-D-Glucosyl-(1-4)-arbutin | |||||||
| β-D-Glucosyl-(1-3)-arbutin |
Laccase-catalyzed reactions
| Product | Donor | Acceptor | Enzyme | Solvent system | Yield (time) | T (°C) | Reference |
|---|---|---|---|---|---|---|---|
| Caffeic acid-chitosan | Caffeic acid | Chitosan | Laccase from | Phosphate buffer | – (24 h) | 30 | Božič et al. |
| Gallic acid-chitosan | Gallic acid | – (24 h) | |||||
| Quercetin-chitosan | Quercetin | Chitosan | – (24 h) | Božič et al. | |||
| Gallic acid-chitosan | Tannic acid | ||||||
| Starch–sodium lignosulfonate graft copolymers | Sodium lignosulfonate | Starch | Sodium acetate | – (4 h) | 30 | Shogren and Biswas | |
| 3,3,5,5-Tetramethoxy biphenyl-4,4-diol | 2,6-Dimethoxyphenol | 2,6-Dimethoxyphenol | Laccase from | Ethyl acetate | – (24 h) | 28 | Adelakun et al. |
| Acetone | – (24 h) | ||||||
| Ferulic acid dimers (5-β, β-β) | Ferulic acid | Ferulic acid | Ethyl acetate or dioxane or ethanol | – (24 h) | Adelakun et al. | ||
| Poly 8-hydroxyquinoline | 8-Hydroxyquinoline | 8-Hydroxyquinoline | Acetone | 76 % (24 h) | 30 | Ncanana and Burton | |
| Resveratrol trans-dehydrodimer | Resveratrol | Resveratrol | Ethyl acetate | 18 % (4 days) | 45 | Nicotra et al. | |
| Laccase from | n-Butanol | 31 % (4 days) | |||||
| Ethyl-ferulate-chitosan | Ethyl ferulate | Chitosan | Laccase from | Phosphate buffer | (4 h) | 30 | Aljawish et al. |
| Ferulic acid-chitosan | Ferulic acid | (4 h) | |||||
| Poly-catechin | (+) - Catechin | (+) - Catechin | Acetone | 95 % (24 h) | RT | Kurisawa et al. | |
| Poly-rutin | Rutin | Rutin | Methanol | 79 % (24 h) | RT | Kurisawa et al. | |
| Oligorutin | Rutin | Rutin | Laccase from | Glycerol/ethanol/buffer | 67 % (24 h) | RT | Uzan et al. |
| Laccase from |